Auris Medical Receives FDA and EMA Guidance for Keyzilen® Late-Stage Clinical Development Program

Ads

You May Also Like

TiGenix Appoints Dr. June Almenoff to its Board of Directors

LEUVEN, Belgium, Sept. 22, 2016 (GLOBE NEWSWIRE) -- TiGenix NV (Euronext Brussels: TIG), an ...

Stemline Therapeutics to Present at the Oppenheimer 28th Annual Healthcare Conference

NEW YORK, March 19, 2018 (GLOBE NEWSWIRE) -- Stemline Therapeutics, Inc. (Nasdaq:STML), a clinical-stage ...

Neovacs and Lupus Europe Join Voices on World Lupus Day

PARIS and BOSTON, May 10, 2017 (GLOBE NEWSWIRE) -- Neovacs (Alternext Paris:ALNEV), a leader ...